The ornamental design that is claimed is shown in solid lines in the drawings. The broken lines in the drawings depict portions of the infusion pump that form no part of the claimed design.
The ornamental design that is claimed is shown in solid lines in the drawings. The broken lines in the drawings depict portions of the infusion pump that form no part of the claimed design.
Number | Name | Date | Kind |
---|---|---|---|
D263997 | Preussner | Apr 1982 | S |
D312307 | Leibson | Nov 1990 | S |
4988337 | Ito | Jan 1991 | A |
D325255 | Busche | Apr 1992 | S |
D326152 | Rutter | May 1992 | S |
D360259 | Ijiri | Jul 1995 | S |
D451596 | Baczkowski | Dec 2001 | S |
D640377 | Amano | Jun 2011 | S |
D645977 | Oonuma | Sep 2011 | S |
D714459 | Develon | Sep 2014 | S |
D871572 | Lacy | Dec 2019 | S |
D884156 | Haug | May 2020 | S |
D888935 | Fang | Jun 2020 | S |
D894373 | Haug | Aug 2020 | S |
D948042 | Bridgers | Apr 2022 | S |
D989292 | Quensel | Jun 2023 | S |
D991448 | Bürger | Jul 2023 | S |
11724026 | Bhandar | Aug 2023 | B2 |
Entry |
---|
Canadian Examination Report from corresponding Canadian Industrial Design Application No. 205525, dated Jan. 28, 2023. |
Korean Office Action for App No. 30-2021-0036886 dated May 25, 2022. |
Baxter Canada Announce First Regulatory Approval of New Novum IQ Infusion Platform, Baxter Corporation, https://www.newswire.ca/news-releases/baxter-canada-announces-first-regulatory-approval-of-new-novum-iq-infusion-platform-896074117.html, Nov. 12, 2020. |